Jingbo Wang

Dr. Jingbo Wang

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2022 in Annals of Surgical Oncology
Verified
Journal Article
Open access
PDF file
JWJingbo Wang
Jingbo Wang
SLSiyi Li
Siyi Li
KWKun Wang
Kun Wang
LZLing Zhu
Ling Zhu
LYLin Yang
Lin Yang
XTXiaofeng Tao
Xiaofeng Tao
Introduction: The postoperative survival of oral squamous cell carcinoma (SCC) relies on precise detection and complete resection of original tumors. The mucosal extension of the tumor is evaluated visually during surgery, but small and flat foci are difficult to detect. Real-time fluorescence imaging may improve detection of tumor margins. Materials and Methods: In the current study, a peptide-based near-infrared (NIR) fluorescence dye, c-MET-binding peptide-indocyanine green (cMBP-ICG), which specifically targets tumor via c-MET binding, was synthetized. A prospective pilot clinical trial then was conducted with oral SCC patients and intraoperatively to assess the feasibility of cMBP-ICG used to detect tumors margins. Fluorescence was histologically correlated to determine sensitivity and specificity. Results: The immunohistochemistry (IHC) results demonstrated increased c-Met expression in oral SCC compared with normal mucosa. Tumor-to-background ratios ranged from 2.71 ± 0.7 to 3.11 ± 1.2 in different concentration groups. From 10 patients with oral SCC, 60 specimens were collected from tumor margins. The sensitivity and specificity of discriminative value derived from cMBP-ICG application in humans were respectively 100% and 75%. Conclusions: Topical application of cMBP-ICG is feasible and safe for optimizing intraoperative visualization and tumor margin detection in oral SCC patients, which could clinically increase the probability of complete resections and improve oncologic outcomes.

1 January 2020 in Dentomaxillofacial Radiology
Verified
Journal Article
Closed access
JWJingbo Wang
Jingbo Wang
XZXue Zhao
Xue Zhao
HSHuimin Shi
Huimin Shi
LZLing Zhu
Ling Zhu
XTXiaofeng Tao
Xiaofeng Tao
Uremic leontiasis ossea (ULO), which occurs in the craniomaxillofacial region, is a sign of terminal stage osteitis fibrosa cystica or brown tumors and primarily caused by secondary hyperparathyroidism induced by renal failure. Pathophysiological changes include osteoclasts or osteoblasts proliferation, bone resorption, bone decalcification, and connective tissue proliferation. In this paper, we report a case of a 24-year-old female patient, who was diagnosed with ULO and presented with multiple facial swellings. Imaging features included zonal patterns with alternating rings of hypo- and hyperattenuated craniomaxillofacial bones, and diffused mixed sclerotic tissues with lytic changes in CT imaging. T1 weighted image and T2 weighted image in MRI were characterized by alternating rings of low and intermediate signal intensity patterns. To the best of our knowledge, this case is the first example of pathologically proved ULO with maxillofacial MRI.

1 April 2024 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
YYYuan Yuan
Yuan Yuan
TFTengfei Fan
Tengfei Fan
JWJingbo Wang
Jingbo Wang
YYYing Yuan
Ying Yuan
XTXiaofeng Tao
Xiaofeng Tao
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide, with 890,000 new cases and 450,000 deaths as of 2018.1 The five-year relative survival rate for head and neck tumors ranged from 53% in 1970 to 67% in 2010.2 The survival rate for the early stages of the disease is 80%, but only 20% to 60% for the late stages.3 The survival rates have not improved significantly over the years due to various shortcomings. First, because of the insidious location of head and neck cancer, most patients are already in the progressive stage (tumor, node, and metastasis stage III-IV) at the initial diagnosis. Second, because of the deep anatomical location of the onset and infiltrating tissues of the lesion connecting the blood vessels and nerves, complete surgical resection (R0 resection) is difficult. Therefore, early diagnosis and improved surgical precision for resection are required to reduce recurrence and improve patient prognosis.

31 January 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
DZDan Zhu
Dan Zhu
XDXiaoqing Dai
Xiaoqing Dai
JWJingbo Wang
Jingbo Wang
CZChunye Zhang
Chunye Zhang
XTXiaofeng Tao
Xiaofeng Tao
LZLing Zhu
Ling Zhu
Objectives: To assess computed tomography (CT) and magnetic resonance imaging (MRI) findings of intramuscular hemangiomas (IMHs) in oral and maxillofacial region and correlate them with the histopathological classifications for selecting optimum management.Methods: The clinical data and pretreatment findings of 32 patients with pathologically proven IMHs on CT (n = 10), MRI (n = 27), or both (n = 5) were analyzed retrospectively. Correspondence of clinical and imaging characters with 3 different pathological classifications (cavernous, capillary, and mixed) of IMHs was studied. A number of pitfalls and overlap of imaging features can result in misdiagnosis of different IMHs lesions.Results: Four patients had multi-muscular lesions, and 28 had single-muscular lesions. The predilection site were the tongue (11 cases, 34.4%) and the masseter muscle (10 cases, 31.2%). Cavernous type (17 cases, 53.1%) was the most common IMHs type. All patients showed slightly hypointense or isointense on T1-weighted imaging, 3 patients showed hyperintense on T2-weighted imaging and the others showed slightly hyperintense. The most common enhancement pattern was progressive (29 cases, 90.6%). The capillary type (9 cases, 28.1%) and mixed type (6 cases, 28.1%) of IMHs on imaging indicated characteristics of lesions with rich blood supply status, the cavernous type (17cases, 53.1%) of IMHs belonged to relatively poor blood supply lesions. A total of 5 patients (15.6%) were initially misdiagnosed, there were recurrences in 4 IMHs patients. Extra functional MRI (fMRI) was performed on these 5 misdiagnosed patients, the average ADC of the 5 patients was 1.50 × 10−3 mm2/s. The presence of vermicular vessels was different among these three types of IMHs.Conclusions: The reason for the misdiagnosis in localized IMHs may be the obvious border of mass-like lesions and the lack of enlarged vessels. Combined evaluation of presence of vermicular vessels and fMRI might be more accurately for determining the IMHs and create a preoperative plan.

16 August 2023 in ChemBioChem
Verified
Journal Article
Closed access
XZXinnan Zhang
Xinnan Zhang
LWLuting Wang
Luting Wang
RHRuimin Huang
Ruimin Huang
JWJingbo Wang
Jingbo Wang
QYQifan Yan
Qifan Yan

8 June 2026 in Cancer Biomarkers
Verified
Journal Article
Open access
JWJingbo Wang
Jingbo Wang
WTWeiqing Tang
Weiqing Tang
WDWeilong Ding
Weilong Ding
DWDongmin Wei
Dongmin Wei
YYYing Yuan
Ying Yuan
XTXiaofeng Tao
Xiaofeng Tao
Background: This study aimed to identify DNA repair–related genes causally affecting OCC risk by integrating multi-omics data using summary data–based Mendelian randomization (SMR). Methods: SMR analyses were performed using GWAS, mQTL, eQTL, and pQTL data. Causal associations were assessed via SMR and HEIDI tests, and colocalization analysis identified shared genetic variants. Findings were validated in the FinnGen_OCC cohort. Results: This study identified 160 methylation sites (96 genes), 30 eQTLs, and 2 pQTLs linked to OCC. Colocalization confirmed 96 mQTLs, 20 eQTLs, and 2 pQTLs (GPN1, HNRNPAB). Five mQTLs (ANK1, HLA C, TERT, TUBB, VHL) replicated in FinnGen. Integration of mQTL and eQTL data highlighted VHL, TP73, and JMJD1C, implicating DNA methylation–mediated regulation. Multi-omics and tissue analyses identified VHL as the most consistent risk gene, supported by colocalization, TCGA HNSC transcriptomic validation (P < 0.01), and DepMap functional data. GEN1 and POU5F1 expression in salivary gland tissue also associated with OCC risk. Conclusion: This multilayer SMR study reveals causal links between DNA repair–related genes and OCC, highlighting VHL as a key driver and suggesting targets for early detection and precision therapy.